Cassandra L. Hodgkinson

Author

Cancer Research UK Manchester Institute

Also Known As

C L Hodgkinson, C. Hodgkinson, C.L. Hodgkinson, Cassandra Hodgkinson, Cassandra L Hodgkinson, Cassandra L. Hodgkinson

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Manchester Institute University of Manchester AstraZeneca (United Kingdom)Manchester Academic Health Science Centre The Christie NHS Foundation Trust

About

Cassandra L. Hodgkinson is an author at Cancer Research UK Manchester Institute specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.1K
2	Cell Biology	4	4	1.1K
3	Cellular Physiology	2	2	52
4	Natural Sciences	1	1	17
5	Biology	1	1	17

Cassandra L. Hodgkinson

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer Cassandra L. Hodgkinson, Christopher J. Morrow, Yaoyong Li, Nature Medicine Tumor BiologyOncologyTumor HeterogeneityMedicineGenetic Profiling	2014	682
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer Radosław Polański, Cassandra L. Hodgkinson, Alberto Fusi, Clinical Cancer Research	2013	345
Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer Louise Carter, Dominic G. Rothwell, Bárbara Mesquita, Nature Medicine Tumor BiologyOncologyTumor HeterogeneityMedicineMolecular Analysis	2016	300
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer Alice Lallo, Kristopher K. Frese, Christopher J. Morrow, Clinical Cancer Research	2018	155
Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer Claire L. Cole, S. Lau, Alison Backen, Cancer Biology & Therapy	2010	93
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study Christopher J. Morrow, F. Trapani, Robert Metcalf, Annals of Oncology	2016	93
Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma Inna V. Linnik, Marietta Scott, Katherine F. Holliday, Magnetic Resonance in Medicine	2013	67
Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity Jeffrey L. Cummings, Cassandra L. Hodgkinson, Rajesh Odedra, Molecular Cancer Therapeutics	2008	64
Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1 Luke Harrison, Dimitra Micha, Martin Brandenburg, Journal of Clinical Investigation ApoptosisCell DeathCancer BiologyCell Death MechanismsTumor Biology	2011	49
Increases in c-Yes Expression Level and Activity Promote Motility But Not Proliferation of Human Colorectal Carcinoma Cells Jane Barraclough, Cassandra L. Hodgkinson, Alison Hogg, Neoplasia	2007	38

Page 1